Crohn's Journey vs Aidy: 80 Metrics or a Quick Check-In?

Aidy keeps daily Crohn's tracking focused, while Crohn's Journey's listings describe a more detailed approach with more than 80 metrics, multiple languages, and an Android app for people who want extensive customization options.

Quick answer: Choose Aidy as the primary Crohn's tracker because its free, quicker routine connects core daily logs with medicines, biologic schedules, modified HBI trends, and clinician reports. Crohn's Journey is the genuine exception for someone who wants the 80-plus fields, Android access, or multiple languages its listings advertise.

Decision factor	Aidy	Crohn's Journey (public claims)
Best for	Sustainable Crohn's tracking	Maximum logging detail
Daily IBD record	Symptoms, stool, meals, medicines	80-plus health and lifestyle fields
Treatment tools	Adherence and biologic workflows	Medication records
Reports and insights	Modified HBI trends and reports	AI correlations and summaries
Access and cost	Free; iPhone or text	iOS, Android, multilingual
Overall pick	Primary Crohn's tracker	Detail-heavy exception

Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.

What the “80+” Claim Actually Covers

The current Crohn's Journey iPhone listing describes more than 80 “bio-markers,” including bowel frequency and Bristol stool type, pain, bloating, fatigue, sleep, weight, nutrition, stress, anxiety, meals, hydration, and physical pacing. It also lists medication and laboratory modules, customizable symptoms, flare logs, goals, care-team contacts, AI correlations, and PDF reports. The Android listing adds urgency, rectal bleeding, nighttime bathroom trips, extraintestinal symptoms, menstrual-cycle tracking, and six AI companions.

Fecal calprotectin and C-reactive protein are biomarkers used in Crohn's monitoring, and the AGA guideline recommends combining biomarkers with symptoms in several settings. Crohn's Journey wins on raw field count and direct lab-result storage, but the number alone does not establish clinical usefulness.

Choosing a detailed Crohn's tracker or low effort IBD tracker

A large menu helps when joint pain, sleep, menstrual timing, stress, or a custom symptom is central to your story. Crohn's Journey says those dimensions can be captured in seconds, but its public pages do not publish completion-time or long-term engagement data for this app.

Aidy concentrates the routine around meals, bowel movements, Bristol stool type, symptom severity, custom symptoms, and medication adherence in a unified daily feed. Aidy also offers tracking by text, which avoids an installation. Sustainability matters because a feature has little value when the record becomes intermittent. In a randomized trial of smartphone-based IBD monitoring, only 50% of participants achieved perfect symptom-monitoring adherence and 30% achieved perfect calprotectin-monitoring adherence (PubMed). Its adherence results illustrate why Aidy's lower-burden design is a meaningful advantage.

Medications, Biologics, Scores, and Reports

Crohn's Journey claims to log medicines, biologics, adherence, and laboratory trends, then generate PDFs. Its store pages do not spell out induction schedules, interval changes, infusion check-ins, or the name and calculation of each advertised standardized assessment. Those omissions limit public verification. The workflow remains hard to evaluate before downloading.

Aidy's current app includes induction and maintenance schedules for named biologics, dose countdowns, injection-site rotation, post-injection or infusion check-ins, and changes in route or interval. It also calculates a modified Harvey-Bradshaw Index from logs and builds doctor-ready reports. HBI is widely used and easier to collect than the longer Crohn's Disease Activity Index, although their relationship is imperfect (PubMed). A symptom score is still one input. Crohn's diagnosis and assessment may require blood tests, stool tests, endoscopy, and imaging (NIDDK). For treatment organization, Aidy has the clearer published workflow.

Treat AI Correlations as Questions

Crohn's Journey advertises daily AI insights, food and lifestyle correlations, and possible flare prediction. These could help someone notice a question worth discussing, but the listing does not link to product-specific validation of those outputs. A systematic review of 137 chatbot health-advice studies found highly variable reporting and limited attention to safety, ethics, and regulation. That finding does not test Crohn's Journey or Aidy directly.

The same restraint applies to Aidy's food-symptom correlations and educational AI chat. NIDDK says a clinician may suggest a food diary to identify foods that seem related to symptoms, while research has not established that specific foods cause or worsen Crohn's symptoms (NIDDK). Patterns can guide better questions. They cannot establish inflammation, predict a flare with certainty, or justify changing treatment without clinical input.

Price, Privacy, Platforms, and the Better Fit

The Crohn's Journey price ranges from $1.99 weekly to $39.99 annually on Apple's US storefront. Its listings advertise iPhone, iPad, Android, and more than 20 languages. The listing does not map prices to features. Apple says location, contact, identifier, and usage data may be linked to a user, while Google Play says no data is collected or shared. That conflict deserves clarification.

Aidy is currently iPhone-only as a native app, in English, with SMS as another route. Aidy is free and has no paid user subscriptions. Aidy is the stronger Crohn's Journey alternative for a sustainable primary record: fewer fields, clearer biologic logistics, a named activity trend, and a defined report. Crohn's Journey is the better specialist choice for maximal customization, lab capture, Android, or multilingual access.